bpc 157 safety data human Dr bpc 157 safety human use

Patients with gastroparesis are characterized by nausea with or without vomiting, and often also similar symptoms as in FD, with a significantly delayed gastric emptying in the absence of mechanical obstruction

Preclinical data shows weight reduction occurs even in ad libitum feeding conditions, meaning caloric intake isn't restricted

This is a commonly made claim by influencers about microdosing, but its a marketing ploy thats not supported by evidence

Due to the role of prostaglandins in renal function and hemodynamics, patients with hypoalbuminemia should be closely observed during therapy due to an increased risk for reduced renal blood flow or volume (3, 5)